Transgenic transchromosomal rodents for making human antibodies

Details for Australian Patent Application No. 2002239422 (hide)

Owner Kirin Beer Kabushiki Kaisha Medarex, Inc.

Inventors Ishida, Isao; Halk, Ed; Tomizuka, Kazuma; Lonberg, Nils

Agent Spruson & Ferguson

Pub. Number AU-B-2002239422

PCT Pub. Number WO02/43478

Priority 60/250,340 30.11.00 US

Filing date 30 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 7 December 2006

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/735 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 December 2006 Application Accepted

  Published as AU-B-2002239422

5 April 2007 Standard Patent Sealed

9 October 2008 Assignment Registered

  Kirin Beer Kabushiki Kaisha; Medarex, Inc. The patent has been assigned to Medarex, Inc.; Kirin Pharma Kabushiki Kaisha

4 June 2009 Assignment Registered

  Medarex, Inc.; Kirin Pharma Kabushiki Kaisha The patent has been assigned to Medarex, Inc.; Kyowa Hakko Kirin Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239423

2002239421